Clinical Trial Update: Serranator POINT FORCE Registry

View source ↗

Summary

Clinical trial update indicating the Serranator POINT FORCE Registry by Cagent Vascular LLC is currently in recruitment for patients with Peripheral Artery Dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula Dysfunction
• Arteriovenous Graft Dysfunction
• Peripheral Artery Disease

Drugs mentioned

• Serranator POINT FORCE (Serranator device)

Snippet

Sponsor: Cagent Vascular LLC | Conditions: Peripheral Artery Disease (PAD), Dysfunctional AV Fistula | Status: RECRUITING